Apyx Medical End Period Cash Flow Over Time
| APYX Stock | USD 1.57 0.01 0.64% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Apyx Medical Performance and Apyx Medical Correlation. Apyx |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apyx Medical. If investors know Apyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apyx Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 1.415 | Quarterly Revenue Growth (0.10) | Return On Assets (0.22) | Return On Equity (1.10) |
The market value of Apyx Medical is measured differently than its book value, which is the value of Apyx that is recorded on the company's balance sheet. Investors also form their own opinion of Apyx Medical's value that differs from its market value or its book value, called intrinsic value, which is Apyx Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apyx Medical's market value can be influenced by many factors that don't directly affect Apyx Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apyx Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Apyx Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apyx Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities End Period Cash Flow Analysis
Compare Apyx Medical and related stocks such as Neuropace, Inogen Inc, and SurModics End Period Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 26.8 M | 19.3 M | 6.7 M | 18.2 M | 16.5 M |
| INGN | 3.9 M | 3.9 M | 15.1 M | 13.5 M | 56.8 M | 66.1 M | 92.9 M | 143 M | 196.6 M | 198 M | 212 M | 235.5 M | 187 M | 125.5 M | 130.8 M |
| SRDX | 16.1 M | 15.5 M | 15.5 M | 43.5 M | 55.6 M | 25 M | 16.5 M | 23.7 M | 30.4 M | 30.8 M | 31.2 M | 19 M | 41.4 M | 36.1 M | 20.9 M |
| LUNG | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 4.1 M | 14.8 M | 231.8 M | 148.7 M | 102 M | 83.8 M | 93.5 M |
| AXGN | 600 K | 8.2 M | 13.9 M | 20.1 M | 8.2 M | 25.9 M | 30 M | 36.5 M | 30.3 M | 41.7 M | 55.6 M | 39 M | 21.5 M | 37 M | 38.9 M |
| KIDS | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 3.9 M | 1.6 M | 42.6 M | 60.7 M | 72 M | 30.1 M | 9 M | 10.5 M | 33 M | 29.7 M |
| LIVN | 8.5 M | 96.7 M | 120.7 M | 103.3 M | 124.2 M | 112.6 M | 39.8 M | 93.6 M | 47.2 M | 61.1 M | 252.8 M | 208 M | 515.6 M | 577.9 M | 606.8 M |
| ELMD | 1.4 M | 1.7 M | 503.6 K | 1.5 M | 3.6 M | 5.1 M | 5.6 M | 7.5 M | 7.8 M | 10.5 M | 11.9 M | 8.2 M | 7.4 M | 16.1 M | 16.9 M |
| AORT | 3.9 M | 21.7 M | 13 M | 37.6 M | 33.4 M | 37.6 M | 56.6 M | 40 M | 42.2 M | 34.3 M | 62 M | 55 M | 39.4 M | 58.9 M | 61.9 M |
| ANIK | 5 M | 35.8 M | 44.1 M | 63.3 M | 100.2 M | 110.7 M | 104.3 M | 133.3 M | 89 M | 157.5 M | 95.8 M | 94.4 M | 86.3 M | 72.9 M | 54.9 M |
| SGHT | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 21.2 M | 61.5 M | 260.7 M | 185 M | 138.1 M | 123 M |
| OFIX | 15.1 M | 33.2 M | 31.1 M | 30.5 M | 36.8 M | 63.7 M | 39.6 M | 81.2 M | 72.2 M | 70.4 M | 96.8 M | 87.8 M | 50.7 M | 37.8 M | 40 M |
| AVNS | 20.1 M | 20.1 M | 47.9 M | 44.1 M | 149 M | 129.5 M | 113.7 M | 219.7 M | 384.5 M | 205.3 M | 111.5 M | 118.5 M | 127.7 M | 87.7 M | 148.9 M |
Apyx Medical and related stocks such as Neuropace, Inogen Inc, and SurModics End Period Cash Flow description
My Equities
My Current Equities and Potential Positions
| Apyx Medical | APYX |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Florida; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.57
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.